These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31239804)

  • 1. Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review.
    Srividya A; Subramanian S; Jambulingam P; Vijayakumar B; Dinesh Raja J
    Res Rep Trop Med; 2019; 10():43-90. PubMed ID: 31239804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis in Fiji: progress towards elimination, 1997-2007.
    Manolas RK; Kama M; Rainima-Qaniuci M; Bechu VD; Tuibeqa S; Winston MV; Ram N; Naqio F; Ichimori K; Capuano C; Ozaki M; Kim SH; Aratchige P; Sahukhan A; Graves PM
    Trop Med Health; 2020; 48():88. PubMed ID: 33132735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.
    Lau CL; Won KY; Lammie PJ; Graves PM
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005108. PubMed ID: 27802280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-TAS as a confirmatory mapping tool for remapping areas with uncertain filarial endemicity to exclude/ include for mass drug administration: A report from field validation in India.
    Panda BB; Krishnamoorthy K; Das A; Jain HK; Dixit S; Rahi M; Somalkar N; Mohanty S; Pati S; Ranjit M; Bal M
    PLoS One; 2023; 18(11):e0293641. PubMed ID: 37922274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of lymphatic filariasis: current perspectives on mass drug administration.
    Gyapong JO; Owusu IO; da-Costa Vroom FB; Mensah EO; Gyapong M
    Res Rep Trop Med; 2018; 9():25-33. PubMed ID: 30050352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The story of Lymphatic Filariasis elimination as a public health problem from Yemen.
    Al-Kubati AS; Al-Samie AR; Al-Kubati S; Ramzy RMR
    Acta Trop; 2020 Dec; 212():105676. PubMed ID: 32828916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
    Stolk WA; Prada JM; Smith ME; Kontoroupis P; de Vos AS; Touloupou P; Irvine MA; Brown P; Subramanian S; Kloek M; Michael E; Hollingsworth TD; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S260-S266. PubMed ID: 29860286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
    Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016.
    Carlingford CN; Melrose W; Mokoia G; Graves PM; Ichimori K; Capuano C; Kim SH; Aratchige P; Nosa M
    Trop Med Health; 2019; 47():20. PubMed ID: 30923457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
    Rebollo MP; Bockarie MJ
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):723-31. PubMed ID: 23879610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.
    Riches N; Badia-Rius X; Mzilahowa T; Kelly-Hope LA
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008289. PubMed ID: 32396575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
    Burgert-Brucker CR; Zoerhoff KL; Headland M; Shoemaker EA; Stelmach R; Karim MJ; Batcho W; Bougouma C; Bougma R; Benjamin Didier B; Georges N; Marfo B; Lemoine JF; Pangaribuan HU; Wijayanti E; Coulibaly YI; Doumbia SS; Rimal P; Salissou AB; Bah Y; Mwingira U; Nshala A; Muheki E; Shott J; Yevstigneyeva V; Ndayishimye E; Baker M; Kraemer J; Brady M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008301. PubMed ID: 32479495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.